The Food and Drug Administration (FDA) has approved Gavreto (pralsetinib) for treatment of patients with metastatic non-small cell lung cancer (NSCLC). Blueprint Medicines Corporation is a precision therapy company focused on genomically…
Category: Lung Cancer Drugs
Get an ideas about the lung cancer treatment drugs, here we provide only information about drugs not to advice them to take without proper doctor guideline. For information about lung cancer drugs browse.
Ramucirumab Injection in Combination with Erlotinib Gets FDA Approval for NSCLC
The Food and Drug Administration (FDA) has approved a 10mg/mL solution for first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) harboring EGFR exon 19 deletions or exon 21 mutations….
U.S. FDA Gives Nod To Bristol-Myers Combo Therapy For Lung Cancer
Non-small cell lung cancer (NSCLC) accounts for about 85% of lung cancer cases. Lung cancer patients in advanced stages of the disease have received a new first-line treatment option. The U.S. Food…
FDA Approves Tabrecta, First Targeted Therapy for NSCLC
The FDA has approved Tabrecta, Novartis for the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. NSCLC is the most common type of lung…
Nintedanib for Treatment of Advanced Lung Cancer
November is recognized as Lung Cancer Awareness Month all over the world. New and advanced researches continue to work in the arena of lung cancer treatment. The University of Barcelona and Hospital…
Pairing Lung and Breast Cancer Drugs More Effective in Killing Cancer Cells
According to the new study, if the drugs used to treat breast and lung cancer are combined, they overcome resistance to treatment. The study is published in the Journal Oncogene and was…
Vizimpro Recommended on NHS for Non-Small Cell Lung Cancer
Health officials have approved life-extending pill for patients with an aggressive form of lung cancer. Vizimpro has been recommended as a first-line treatment for people with a type of non-small cell lung…
Tecentriq Plus Chemotherapy Approved for Small Cell Lung Cancer
The Food and Drug Administration (FDA) has approved Tecentriq, in combination with carboplatin and etoposide for the first-line treatment of patients suffering from extensive-stage small cell lung cancer. Out of total lung…
Drug: Tagrisso (Osimertinib) to Treat NSCLC
Osimertinib or Tagrisso is an FDA-approved drug by FDA as a frontline treatment for patients with non-small cell lung cancer (NSCLC). It is indicated for the first-line lung cancer treatment of patients…
Research: Scientists Discover New Drug Target for Lung Cancer
A group of researchers at the University of Cambridge have identified lung squamous cell carcinoma (LUSC) cells containing high amounts of protein called BCL11A. LUSC occurs when abnormal lung cells form a…
Drug: Nivolumab to Treat NSCLC
About Nivolumab Nivolumab or Opdivo is a prescription drug used for the treatment of advanced non-small cell lung cancer. It is given to those patients where lung cancer has spread and platinum-based…
Drug: Paclitaxel to Treat NSCLC
In the past two decades, little progress has been made in the field of lung cancer treatment. Patients with advanced level of cancer find it difficult to survive. Non-small cell lung cancer…